Mortality Profile of Tuberculosis Patients in Mandya District - A Cross-Sectional Study

Main Article Content

Shashank Shetty
https://orcid.org/0000-0002-9275-623X
Almas Begum A

Abstract

Introduction: Tuberculosis (TB) remains a leading cause of mortality globally, especially among immunocompromised individuals such as those living with HIV. In 2022, TB accounted for 1.3 million deaths among HIV-negative individuals and 167,000 among PLHIV. Mortality in TB patients is influenced by factors like age, comorbidities (e.g., malignancy, liver and renal failure), and radiographic patterns. The COVID-19 pandemic significantly disrupted TB services, resulting in reduced case detection and a subsequent rise in TB deaths. Risk factors like sputum positivity, drug resistance, diabetes, and HIV were found to contribute to TB mortality. Objectives are to describe the mortality pattern of TB patients registered under NTEP in Mandya district (2018–2023) and to identify risk factors associated with TB mortality. Methodology: A facility-based cross-sectional study was conducted involving 168 TB death cases reported between Feb 2018 and Dec 2023. Data were collected via telephonic interviews with close relatives. Complete enumeration was used, and inclusion criteria focused on confirmed TB deaths under NTEP. Data were analyzed using descriptive and bivariate methods. Results: Most deaths occurred in males (76%) and individuals aged >60 years (39.2%). Pulmonary TB was present in 84% of cases, and 91.6% were on treatment. Respiratory insufficiency was the leading cause of death (79.6%). Deaths at home were more common (62%). COVID-19 years showed fewer deaths but with shorter diagnosis-to-death durations and longer hospital stays, suggesting pandemic-related service disruptions. Conclusion: TB mortality (2018–2023) in Mandya was higher among older, less literate males, with home deaths and COVID-19-related care disruptions highlighting the need for early detection and better healthcare access.

Downloads

Download data is not yet available.

Article Details

Section

Original Article

How to Cite

1.
Mortality Profile of Tuberculosis Patients in Mandya District - A Cross-Sectional Study. JEFI [Internet]. 2025 Jun. 30 [cited 2025 Jul. 1];3(2). Available from: https://efi.org.in/journal/index.php/JEFI/article/view/82

References

1. Tobin, E.H. (2024) Tuberculosis overview, StatPearls [Internet]. [Accessed: 27 January 2025]. Available at: https://www.ncbi.nlm.nih.gov/books/

2. Alisjahbana B, Sahiratmadja E, Nelwan EJ, Purwa AM, Ahmad Y, Ottenhoff TH, et al. The mortality of tuberculosis patients in Indonesia and its associated factors. BMC Infect Dis 2014;14-5

3. Centers for Disease Control and Prevention. TB and HIV Coinfection [Internet]. Atlanta: CDC; 2023 [cited 2024 Oct 27]. Available from: https://www.cdc.gov/tb/topic/basics/tbhivcoinfection.html

4. World Health Organization. Global Tuberculosis Report 2023 [Internet]. Geneva: WHO; 2023 [cited 2024 Oct 27]. Available from: https://www.who.int/news-room/fact-sheets/detail/tuberculosis

5. Kumar MS, Surendran D, Manu MS, Rakesh PS, Balakrishnan S. Mortality due to TB-COVID-19 coinfection in India. The International Journal of Tuberculosis and Lung Disease. 2021 Mar 1;25(3):250-1.

6. Sridhar R, Viswanathan VK, Singh R, Keyzare R. Analysis of tuberculosis-related mortality during the first wave of the COVID pandemic at GHTM, Tambaram Sanatorium. Journal of Association of Pulmonologist of Tamil Nadu. 2021 May 1;4(2):65-8.

7. Hazra D, Chawla K, Shenoy VP, Pandey AK, Nayana S. The aftermath of COVID-19 pandemic on the diagnosis of TB at a tertiary care hospital in India. Journal of Infection and Public Health. 2021 Aug 1;14(8):1095-8.

8. Varshney K, Patel H, Kamal S (April 29, 2023) Trends in Tuberculosis Mortality Across India: Improvements Despite the COVID-19 Pandemic. Cureus 15(4): e38313. DOI 10.7759/cureus.38313

9. Sharma P, Khokhar A. Risk factors and perceptions about coronavirus disease among tuberculosis patients in Delhi, India: A cross-sectional study. Indian journal of tuberculosis. 2022 Oct 1;69(4):655-62.

10. Krishnamoorthy Y, Ezhumalai K, Murali S, Rajaa S, Majella M, Sarkar S, et al. Development of prognostic scoring system for predicting 1-year mortality among pulmonary tuberculosis patients in South India. J Public Health.

11. Straetemans M, Glaziou P, Bierrenbach A, Sismanidis C, Van Der Werf M. Assessing tuberculosis case fatality ratio: A meta-analysis. PLoS ONE. 2011;6.

12. Alemu A, Bitew Z, Worku T, Gamtesa D, Alebel A. Predictors of mortality in patients with drug-resistant tuberculosis: A systematic review and meta-analysis. PLoS ONE. 2021;16.

13. Taneja K, Mittal C, Saini S. Delays in the diagnosis and treatment of TB in India: A retrospective study. J Trop Med. 2022;2022:4532849.

14. Vashishtha R, Kumar P, Sharma SK. COVID-19 and tuberculosis: A study on the Indian healthcare crisis. J Clin Tuberc Other Mycobact Dis. 2021;23:100239.

15. Meneguim AC, Ferreira MD, et al. Impact of the COVID-19 pandemic on tuberculosis care in India: A systematic review. Int J Tuberc Lung Dis. 2021;25(8):784–91.

16. Pai M, Kasaeva T, Swaminathan S. Covid-19’s devastating effect on tuberculosis care – A path to recovery. N Engl J Med. 2022;386(16):1490–93.

17. Indian Council of Medical Research (ICMR). Decentralized care models and TB treatment strategies in India. Indian J Med Res. 2023;157(3):234–41.

Similar Articles

You may also start an advanced similarity search for this article.